Skip to main content
. 2017 Aug 31;123(5):1371–1385. doi: 10.1152/japplphysiol.00321.2017

Table 2.

Autosomal gene regions acted upon by natural selection in high-altitude populations as identified in studies published from 2004 to 2017

Andeans Tibetans Ethiopians
BRINP3 (34) ANGPT1 (151) ADRBK1 (1)
CBS (40)
EDNRA (14, 16) CDH13 (151) ARNT2 (9, 129)
EGLN1 (14, 16) ECE1 (151) ASF1B (1)
ELTD1 (40)
ET-1 (106) EGLN1 (14, 61, 116, 134, 151, 163, 167) BHLHE41 (64)
FAM213A (147) EPAS1 (9, 14, 61, 116, 151, 163, 167) CBARA1 (129)
NOS2 (14, 16, 34) FOXO1 (151) CUL3 (1)
PRKAA1 (14, 16) HMOX2 (165) CORO1B (1)
SFTPD (147) KCTD12 (61) HLA-DRA (1)
TP53 pathway (69) LEPR (151) MAPKAPK2 (1)
VEGFB (40)
TBX5 (34) PPARA (134) Multiple (CIC, LIPE, PAFAH1B3) (146)
PTGIS (61) THRB (129)
RUNX1 (151) VAV3 (129)
RYR1 (151)
TED (93)
VDR (61)

Numbers in parentheses are reference citations. ADRBK1, adrenergic beta receptor kinase 1; ANGPT1, angiopoietin 1; ARNT2, aryl hydrocarbon receptor nuclear translocator 2; ASF1B, anti-silencing function 1B histone chaperone; BHLHE41, basic helix-loop-helix family member e41; BRINP3, BMP/retinoic acid inducible neural specific 3; CBARA1, mitochondrial calcium uptake 1; CBS, cystathionine beta-synthase; CDH13, cadherin 13; CIC, capicua transcriptional repressor; CUL3, cullin 3; CORO1B, coronin actin binding protein 1B; ECE1, endothelin converting enzyme 1; EDNRA, endothelin receptor type A; EGLN1,  egl-9 family hypoxia-inducible factor 1; ELTD1, latrophilin and seven transmembrane domain-containing protein 1; EPAS1, endothelial PAS domain protein 1; ET-1, endothelin 1; FAM213A, family with sequence similarity 213 member A; FOXO1, forkhead box O1; HLA-DRA, major histocompatibility complex, class II, DR alpha; KCTD12, K+ channel tetramerization domain containing 12; LEPR, leptin receptor; LIPE, lipase E hormone sensitive type; MAPKAPK2, mitogen-activated protein kinase-activated protein kinase 2; NOS2, nitric oxide synthase 2; PAFAH1B3, platelet activating factor acetylhydrolase 1b catalytic subunit 3; PPARA, peroxisome proliferator-activated receptor alpha; PRKAA1, protein kinase AMP-activated, alpha 1 catalytic subunit; PTGIS, prostaglandin I2 synthase; RUNX1, runt related transcription factor 1; RYR1, ryanodine receptor 1; SFTPD, surfactant protein D; SNP, single-nucleotide polymorphism; TBX5, T-box 5; TED, Tibetan enriched deletion; THRB, thyroid hormone receptor beta; TP53, tumor protein p53; VAV3, vav guanine nucleotide exchange factor 3; VDR, vitamin D3 receptor; VEGFB, vascular endothelial growth factor B.